Literature DB >> 32896596

Accuracy of commercial panels to evaluate myositis autoantibodies: A single-institution perspective.

Adarsh Ravishankar1, Josef S Concha1, Daisy Yan1, Christina E Bax1, Andrea C Yeguez1, Livia Casciola-Rosen2, Victoria P Werth3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32896596      PMCID： PMC7841648          DOI： 10.1016/j.jaad.2020.08.111

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Utilization patterns and performance of commercial myositis autoantibody panels in routine clinical practice.

Authors:  P C Gandiga; J Zhang; S Sangani; P Thomas; V P Werth; M D George
Journal:  Br J Dermatol       Date:  2019-08-18       Impact factor: 9.302

2.  Distinct dermatomyositis populations are detected with different autoantibody assay platforms.

Authors:  David F Fiorentino; Laura Gutierrez-Alamillo; David Hines; Qingyuan Yang; Livia Casciola-Rosen
Journal:  Clin Exp Rheumatol       Date:  2019-07-19       Impact factor: 4.473

Review 3.  The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases.

Authors:  Minoru Satoh; Shin Tanaka; Edward K L Chan
Journal:  Front Immunol       Date:  2015-04-21       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.